PH12927A - Vingamine derivatives - Google Patents

Vingamine derivatives

Info

Publication number
PH12927A
PH12927A PH16634A PH16634A PH12927A PH 12927 A PH12927 A PH 12927A PH 16634 A PH16634 A PH 16634A PH 16634 A PH16634 A PH 16634A PH 12927 A PH12927 A PH 12927A
Authority
PH
Philippines
Prior art keywords
vingamine
derivatives
vingamine derivatives
Prior art date
Application number
PH16634A
Other languages
English (en)
Inventor
P Pfaffli
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1768973A external-priority patent/CH588488A5/de
Priority claimed from CH162174A external-priority patent/CH596207A5/de
Priority claimed from CH176574A external-priority patent/CH593283A5/de
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH12927A publication Critical patent/PH12927A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D461/00Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH16634A 1973-12-18 1974-12-16 Vingamine derivatives PH12927A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1768973A CH588488A5 (en) 1973-12-18 1973-12-18 Vincamine derivs for treating behaviour disorders - by ring closure of indoloquinolizine deriv
CH162174A CH596207A5 (en) 1974-02-06 1974-02-06 Vincamine derivs for treating behaviour disorders
CH176574A CH593283A5 (en) 1974-02-08 1974-02-08 Vincamine derivs for treating behaviour disorders - by ring closure of indoloquinolizine deriv

Publications (1)

Publication Number Publication Date
PH12927A true PH12927A (en) 1979-10-10

Family

ID=27173122

Family Applications (1)

Application Number Title Priority Date Filing Date
PH16634A PH12927A (en) 1973-12-18 1974-12-16 Vingamine derivatives

Country Status (16)

Country Link
JP (1) JPS5817474B2 (ja)
CA (1) CA1051899A (ja)
DD (1) DD116043A5 (ja)
DE (1) DE2458164A1 (ja)
DK (1) DK139358B (ja)
ES (3) ES432952A1 (ja)
FI (1) FI59096C (ja)
FR (1) FR2254342B1 (ja)
GB (1) GB1492579A (ja)
HK (1) HK53980A (ja)
IE (1) IE40791B1 (ja)
MY (1) MY8100186A (ja)
NL (1) NL7416237A (ja)
NO (1) NO744456L (ja)
PH (1) PH12927A (ja)
SE (1) SE422798B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2396759A1 (fr) * 1977-07-06 1979-02-02 Omnium Chimique Sa Nouveaux composes heterocycliques, derives de la vincamine, leur preparation et leur application comme medicaments, notamment dans le domaine des insuffisances cardio-circulatoires, cerebro-vasculaires ou respiratoires
HU177498B (en) * 1977-07-27 1981-10-28 Richter Gedeon Vegyeszet Process for preparing new vincinic acid and apovincinic acid esters
FR2423493A1 (fr) * 1977-10-19 1979-11-16 Omnium Chimique Sa Nouveaux composes heterocycliques derives de l'apo-vincamine, leur preparation et leur application comme medicaments, notamment dans le domaine des insuffisances cardio-circulatoires, cerebro-vasculaires et respiratoires
FR2407931A1 (fr) * 1977-11-02 1979-06-01 Synthelabo Derives de l'eburnamenine et leur application en therapeutique
JPS5493000A (en) * 1977-12-28 1979-07-23 Sandoz Ag Improvement of organic compound
DE2800063A1 (de) * 1978-01-02 1979-07-12 Sandoz Ag 10-bromvincamin, seine herstellung und verwendung
US4283401A (en) * 1978-07-12 1981-08-11 Richter Gedeon Vegyeszeti Gyar Rt Process for the preparation of 11-bromo-vincaminic acid ester derivatives and their use in protecting animals against cerebral hypoxy
US4315011A (en) * 1978-07-12 1982-02-09 Richter Gedeon Vegyeszeti Gyar Rt. 1-Alkyl-9-bromohexahydroindolo quinolizium salts and use thereof to increase blood flow
US4285949A (en) * 1978-12-11 1981-08-25 Omnichem Societe Anonyme Vincamine derivatives, their preparation and therapeutical use
HU177732B (en) * 1978-12-15 1981-12-28 Richter Gedeon Vegyeszet Process for producing 10-bromo-vincamine and acid additional salts thereof,and 10-bromo-14-epivincamine
HU180928B (en) * 1979-08-06 1983-05-30 Richter Gedeon Vegyeszet Process for preparing new brominated 15-hydroxy-e-homo-eburane derivatives
HU180929B (en) * 1979-08-13 1983-05-30 Richter Gedeon Vegyeszet Process for producing new bromo-vincamone derivatives
HU185305B (en) * 1981-08-23 1985-01-28 Richter Gedeon Vegyeszet Process for preparing vincine and apovincine
HU183326B (en) * 1981-02-11 1984-04-28 Richter Gedeon Vegyeszet Process for preparing new apovincaminol-3',4',5'-trimethoxy-benzoates substituted in the a ring and acid addition salts thereof
ES8604952A1 (es) * 1985-11-05 1986-03-16 Covex Sa Procedimiento para la preparacion de los compuestos 10-11 bromo-14,15-dihidro-14 b-hidroxi-(3x,16x)-eburnamenina-14- carboxilato de metilo
US4883876A (en) * 1987-09-07 1989-11-28 Taisho Pharmaceutical Co., Ltd. Acylated vincaminic acid derivatives

Also Published As

Publication number Publication date
MY8100186A (en) 1981-12-31
FR2254342B1 (ja) 1978-07-21
AU7648374A (en) 1976-06-17
DE2458164C2 (ja) 1991-04-18
HK53980A (en) 1980-10-03
SE422798B (sv) 1982-03-29
JPS50105700A (ja) 1975-08-20
CA1051899A (en) 1979-04-03
DK139358C (ja) 1979-07-09
SE7415416L (ja) 1975-06-19
DD116043A5 (ja) 1975-11-05
ES432952A1 (es) 1977-02-16
DK139358B (da) 1979-02-05
FI59096B (fi) 1981-02-27
GB1492579A (en) 1977-11-23
JPS5817474B2 (ja) 1983-04-07
DE2458164A1 (de) 1975-06-26
IE40791B1 (en) 1979-08-15
DK639774A (ja) 1975-08-25
FR2254342A1 (ja) 1975-07-11
ES450741A1 (es) 1978-03-16
ES450740A1 (es) 1977-12-16
IE40791L (en) 1975-06-18
FI59096C (fi) 1981-06-10
NL7416237A (nl) 1975-06-20
NO744456L (ja) 1975-07-14
FI355274A (ja) 1975-06-19

Similar Documents

Publication Publication Date Title
ZA747964B (en) 2-cyclohexene-1-one derivatives
HK13379A (en) Pyrazino-isoquinoline derivatives
ZA744331B (en) 1-hydroxyphenyl-2-amidoalkylaminoesthanol derivatives
PH14530A (en) 7-methoxycephalosporin derivatives
AU6820074A (en) Azolyl-amidines
PH12927A (en) Vingamine derivatives
ZM9174A1 (en) Azapurinone derivatives
GB1483352A (en) Phenyl-alkenol and-alkanol derivatives
IL43704A0 (en) Lactamimide derivatives
PH12303A (en) Thienotriazolodiazepine derivatives
HK181A (en) Benzylpyrimidine derivatives
HK54080A (en) Dihydroergopeptine derivatives
AU6566574A (en) Photoelectrophoresis
ZM7974A1 (en) Nitro-heterocyclic derivatives
AU6616174A (en) Flag-stone
AU6797274A (en) Dichlorothiazolylureas
AU6598974A (en) 6-amino-th-benzocyclohepten-7-ones
ZA747612B (en) Anhydrise derivatives
ZA741229B (en) Nuceleoside derivatives
IL44831A0 (en) Pyrazinoisoquinoline derivatives
AU6797174A (en) Motor-timer
GB1408550A (en) Gitoxigenin-digitoxoside derivatives
AU7333774A (en) Arylchalcogeno-hydrocarbon derivatives
AU7333674A (en) Arylchalcogeno-hydrocarbon derivatives
ZA741439B (en) Benzenesulfonylurea derivatives